Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,376 INR | -1.42% | -0.05% | +13.98% |
05-03 | INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh | RE |
05-02 | Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4 | MT |
Sales 2024 | 42.09B 504M 689M | Sales 2025 * | 47.29B 566M 774M | Capitalization | 297B 3.56B 4.86B |
---|---|---|---|---|---|
Net income 2024 | 8.16B 97.76M 134M | Net income 2025 * | 9.46B 113M 155M | EV / Sales 2024 | 6.67 x |
Net cash position 2024 * | 7.97B 95.47M 130M | Net cash position 2025 * | 8.39B 100M 137M | EV / Sales 2025 * | 6.1 x |
P/E ratio 2024 |
34.4
x | P/E ratio 2025 * |
31.8
x | Employees | 7,713 |
Yield 2024 * |
0.85% | Yield 2025 * |
0.76% | Free-Float | 50.31% |
Latest transcript on Ajanta Pharma Limited
1 day | -1.42% | ||
1 week | -0.05% | ||
Current month | +7.12% | ||
1 month | +11.00% | ||
3 months | +9.86% | ||
6 months | +25.64% | ||
Current year | +13.98% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 98-12-31 | |
Chief Executive Officer | 52 | 95-12-31 | |
Director of Finance/CFO | 59 | 98-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 95-12-31 | |
Chairman | 77 | 79-12-30 | |
Director/Board Member | 78 | 08-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2,376 | -1.42% | 11,315 |
24-05-09 | 2,410 | +1.82% | 5,116 |
24-05-08 | 2,367 | -1.32% | 11,304 |
24-05-07 | 2,399 | -0.68% | 17,241 |
24-05-06 | 2,415 | +1.60% | 9,833 |
Delayed Quote Bombay S.E., May 10, 2024 at 06:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- AJANTPHARM Stock
- AJANTPHARM Stock